People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Telesis Bio Inc. | — | Biotech / Pharma | Series B | $28.0M | $308.2M | 2023 |
Daniel G. Gibson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel G. Gibson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Franklin R. Witney | 1 | 2 |
| Christine A. Tsingos | 1 | 2 |
| Paul V. Meister | 1 | 1 |
| William F. Snider | 1 | 1 |
| Andrea L. Jackson | 1 | 1 |
| Todd R. Nelson | 1 | 1 |
| Robert H. Cutler | 1 | 1 |
| Annette V. Tumolo | 1 | 1 |
| Jami A. Nachtsheim | 1 | 1 |
| Eric H. Esser | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.